25-Hydroxyvitamin D, dementia, and cerebrovascular… [Neurology. 2010] – PubMed – NCBI

Posted on January 15, 2013 by Maurice Preter MD

Neurology. 2010 Jan 5;74(1):18-26. doi: 10.1212/WNL.0b013e3181beecb7. Epub 2009 Nov 25. 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Buell JS, Dawson-Hughes B, Scott TM, Weiner DE, Dallal GE, Qui WQ, Bergethon P, Rosenberg IH, Folstein MF, Patz … Continue reading →

Posted in Fifth Avenue Concierge Medicine, keto, Psychiatry/Neurology | Tagged , , , |

Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.

Posted on January 15, 2013 by Maurice Preter MD

Lancet Neurol. 2011 May;10(5):436-45. doi: 10.1016/S1474-4422(11)70045-X. Epub 2011 Mar 31. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. Banwell B, Bar-Or A, Arnold DL, Sadovnick D, Narayanan S, McGowan M, … Continue reading →

Posted in Fifth Avenue Concierge Medicine, keto, Psychiatry/Neurology | Tagged , , |

A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis.

Posted on January 15, 2013 by Maurice Preter MD

J Neurol Neurosurg Psychiatry. 2012 May;83(5):565-71. doi: 10.1136/jnnp-2011-301876. Epub 2012 Feb 22. A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis. Soilu-Hänninen M, Aivo J, Lindström … Continue reading →

Posted in Fifth Avenue Concierge Medicine, keto, Psychiatry/Neurology | Tagged , , |

A Randomised, Double-Blind, Placebo-Controlled Trial with Vitamin D3 in MS: Subgroup Analysis of Patients with Baseline Disease Activity Despite Interferon Treatment.

Posted on January 15, 2013 by Maurice Preter MD

Mult Scler Int. 2012;2012:802796. doi: 10.1155/2012/802796. Epub 2012 Aug 5. A Randomised, Double-Blind, Placebo-Controlled Trial with Vitamin D3 in MS: Subgroup Analysis of Patients with Baseline Disease Activity Despite Interferon Treatment. Aivo J, Lindsröm BM, Soilu-Hänninen M. Source Department of … Continue reading →

Posted in Fifth Avenue Concierge Medicine, keto, Psychiatry/Neurology | Tagged , , |

Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis – Mowry – 2012 – Annals of Neurology – Wiley Online Library

Posted on January 15, 2013 by Maurice Preter MD

Vitamin D and New MRI Lesions >>In univariate models, each 10ng/ml higher vitamin D level was associated with a 15% lower risk of later developing new T2 lesions (IRR, 0.85; 95% CI, 0.76–0.95; p = 0.005). The multivariate results were … Continue reading →

Posted in keto, Psychiatry/Neurology | Tagged , , |